P2RX7 and neoplasm: In addition, ATP released from dying tumor cells upon chemotherapy induced NLRP3 inflammasome activation and IL-1β secretion from dendritic cells through P2X7 purinergic receptor in the breast tumor microenvironment27 (Figs. 1 and 3).